![]() |
Volumn 18, Issue 1, 2008, Pages 168-172
|
A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component
|
Author keywords
CK7; Endometrioid adenocarcinoma; Epithelial ovarian cancer; Neometaplasia; Yolk sac tumor
|
Indexed keywords
ALPHA FETOPROTEIN;
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CA 125 ANTIGEN;
CARBOPLATIN;
CISPLATIN;
CYTOKERATIN 7;
EPITHELIAL MEMBRANE ANTIGEN;
ETOPOSIDE;
HORMONE RECEPTOR;
PACLITAXEL;
SEX HORMONE;
ADULT;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PATIENT;
CASE REPORT;
CELL DIFFERENTIATION;
ENDOMETRIOID CARCINOMA;
FEMALE;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
MULTIPLE CYCLE TREATMENT;
OVARY ADENOCARCINOMA;
POSTMENOPAUSE;
PRIORITY JOURNAL;
PROGNOSIS;
TREATMENT INDICATION;
TREATMENT RESPONSE;
YOLK SAC TUMOR;
ALPHA-FETOPROTEINS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
BRIDGED COMPOUNDS;
CARCINOMA, ENDOMETRIOID;
CISPLATIN;
ENDODERMAL SINUS TUMOR;
ETOPOSIDE;
FEMALE;
HUMANS;
IMMUNOENZYME TECHNIQUES;
MIDDLE AGED;
OVARIAN NEOPLASMS;
PLATINUM;
TAXOIDS;
|
EID: 38049072792
PISSN: 1048891X
EISSN: 15251438
Source Type: Journal
DOI: 10.1111/j.1525-1438.2007.00952.x Document Type: Article |
Times cited : (29)
|
References (9)
|